Abstract
Radiotherapy is widely utilized as primary therapy for clinically localized prostate cancer. Biochemical recurrence after external radiotherapy or brachytherapy occurs in up to 60 % of patients treated for prostate cancer within 10 years. Salvage radical prostatectomy represents a secondary local treatment with curative intent in patients with organ confined prostate cancer recurrences following radiation therapy. Patients most likely to benefit from salvage prostatectomy have low-risk disease, a pretreatment PSA velocity <2.0 ng/ml per year at the time of initial presentation, an interval to PSA failure >3 years, and a PSA doubling time >12 months. In experienced hands, morbidity is low with a continence rate of approximately 80 % depending on the type of previous radiation therapy. Long-term oncological control can be achieved in more than 75 % of the patients. Despite these well-established oncological outcomes, salvage radical prostatectomy is infrequently performed or reported.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Agarwal PK, Sadetsky N, Konety BR, Resnick MI, Carroll PR (2008) Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes. Cancer 112(2):307–314. doi:10.1002/cncr.23161
Bianco FJ Jr, Scardino PT, Stephenson AJ, Diblasio CJ, Fearn PA, Eastham JA (2005) Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy. Int J Radiat Oncol Biol Phys 62(2):448–453. doi:10.1016/j.ijrobp.2004.09.049
Carson CC 3rd, Zincke H, Utz DC, Cupps RE, Farrow GM (1980) Radical prostatectomy after radiotherapy for prostatic cancer. J Urol 124(2):237–239
Chade DC, Eastham J, Graefen M, Hu JC, Karnes RJ, Klotz L, Montorsi F, van Poppel H, Scardino PT, Shariat SF (2012) Cancer control and functional outcomes of salvage radical prostatectomy for radiation-recurrent prostate cancer: a systematic review of the literature. Eur Urol 61(5):961–971. doi:10.1016/j.eururo.2012.01.022
Chade DC, Shariat SF, Cronin AM, Savage CJ, Karnes RJ, Blute ML, Briganti A, Montorsi F, van der Poel HG, Van Poppel H, Joniau S, Godoy G, Hurtado-Coll A, Gleave ME, Dall’Oglio M, Srougi M, Scardino PT, Eastham JA (2011) Salvage radical prostatectomy for radiation-recurrent prostate cancer: a multi-institutional collaboration. Eur Urol 60(2):205–210. doi:10.1016/j.eururo.2011.03.011
de Jong IJ, Pruim J, Elsinga PH, Vaalburg W, Mensink HJ (2003) 11C-choline positron emission tomography for the evaluation after treatment of localized prostate cancer. Eur Urol 44(1):32–38 (discussion 38–39)
Gheiler EL, Tefilli MV, Tiguert R, Grignon D, Cher ML, Sakr W, Pontes JE, Wood DP Jr (1998) Predictors for maximal outcome in patients undergoing salvage surgery for radio-recurrent prostate cancer. Urology 51(5):789–795
Gotto GT, Yunis LH, Vora K, Eastham JA, Scardino PT, Rabbani F (2010) Impact of prior prostate radiation on complications after radical prostatectomy. J Urol 184(1):136–142. doi:10.1016/j.juro.2010.03.031
Heidenreich A, Richter S, Thuer D, Pfister D (2010) Prognostic parameters, complications, and oncologic and functional outcome of salvage radical prostatectomy for locally recurrent prostate cancer after 21st-century radiotherapy. Eur Urol 57(3):437–443. doi:10.1016/j.eururo.2009.02.041
Jadvar H, Alavi A (2009) Role of imaging in prostate cancer. PET clinics 4(2):135–138. doi:10.1016/j.cpet.2009.05.003
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69–90. doi:10.3322/caac.20107
Kimura M, Mouraviev V, Tsivian M, Mayes JM, Satoh T, Polascik TJ (2010) Current salvage methods for recurrent prostate cancer after failure of primary radiotherapy. BJU international 105(2):191–201. doi:10.1111/j.1464-410X.2009.08715.x
Leonardo C, Simone G, Papalia R, Franco G, Guaglianone S, Gallucci M (2009) Salvage radical prostatectomy for recurrent prostate cancer after radiation therapy. Int J Urol Official J Jpn Urol Assoc 16(6):584–586. doi:10.1111/j.1442-2042.2008.02209.x
Masterson TA, Stephenson AJ, Scardino PT, Eastham JA (2005) Recovery of erectile function after salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy. Urology 66(3):623–626. doi:10.1016/j.urology.2005.04.002
Mohler J, Bahnson RR, Boston B, Busby JE, D’Amico A, Eastham JA, Enke CA, George D, Horwitz EM, Huben RP, Kantoff P, Kawachi M, Kuettel M, Lange PH, Macvicar G, Plimack ER, Pow-Sang JM, Roach M 3rd, Rohren E, Roth BJ, Shrieve DC, Smith MR, Srinivas S, Twardowski P, Walsh PC (2010) NCCN clinical practice guidelines in oncology: prostate cancer. J Natl Comprehensive Cancer Netw JNCCN 8(2):162–200
Mottet N, Bellmunt J, Bolla M, Joniau S, Mason M, Matveev V, Schmid HP, Van der Kwast T, Wiegel T, Zattoni F, Heidenreich A (2011) EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer. Eur Urol 59(4):572–583. doi:10.1016/j.eururo.2011.01.025
Nguyen PL, D’Amico AV, Lee AK, Suh WW (2007) Patient selection, cancer control, and complications after salvage local therapy for postradiation prostate-specific antigen failure: a systematic review of the literature. Cancer 110(7):1417–1428. doi:10.1002/cncr.22941
Pontes JE, Montie J, Klein E, Huben R (1993) Salvage surgery for radiation failure in prostate cancer. Cancer 71(3 Suppl):976–980
Roach M 3rd, Hanks G, Thames H Jr, Schellhammer P, Shipley WU, Sokol GH, Sandler H (2006) Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix consensus conference. Int J Radiat Oncol Biol Phys 65(4):965–974. doi:10.1016/j.ijrobp.2006.04.029
Rogers E, Ohori M, Kassabian VS, Wheeler TM, Scardino PT (1995) Salvage radical prostatectomy: outcome measured by serum prostate specific antigen levels. J Urol 153(1):104–110. doi:10.1097/00005392-199501000-00037
Sanderson KM, Penson DF, Cai J, Groshen S, Stein JP, Lieskovsky G, Skinner DG (2006) Salvage radical prostatectomy: quality of life outcomes and long-term oncological control of radiorecurrent prostate cancer. J Urol 176(5):2025–2031 (discussion 2031–2022). doi:10.1016/j.juro.2006.07.075
Stephenson AJ, Scardino PT, Bianco FJ Jr, DiBlasio CJ, Fearn PA, Eastham JA (2004) Morbidity and functional outcomes of salvage radical prostatectomy for locally recurrent prostate cancer after radiation therapy. J Urol 172(6 Pt 1):2239–2243
van der Poel HG, Beetsma DB, van Boven H, Horenblas S (2007) Perineal salvage prostatectomy for radiation resistant prostate cancer. Eur Urol 51(6):1565–1571 (discussion 1572). doi:10.1016/j.eururo.2006.08.011
Walsh PC (1998) Anatomic radical prostatectomy: evolution of the surgical technique. J Urol 160(6 Pt 2):2418–2424
Ward JF, Sebo TJ, Blute ML, Zincke H (2005) Salvage surgery for radiorecurrent prostate cancer: contemporary outcomes. J Urol 173(4):1156–1160. doi:10.1097/01.ju.0000155534.54711.60
Zelefsky MJ, Fuks Z, Hunt M, Yamada Y, Marion C, Ling CC, Amols H, Venkatraman ES, Leibel SA (2002) High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys 53(5):1111–1116
Zietman AL, DeSilvio ML, Slater JD, Rossi CJ Jr, Miller DW, Adams JA, Shipley WU (2005) Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. JAMA J Am Med Assoc 294(10):1233–1239. doi:10.1001/jama.294.10.1233
Zincke H (1992) Radical prostatectomy and exenterative procedures for local failure after radiotherapy with curative intent: comparison of outcomes. J Urol 147(3 Pt 2):894–899
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Kübler, H., Maurer, T., Horn, T., Gschwend, J.E. (2014). Salvage Prostatectomy After Radiotherapy. In: Geinitz, H., Roach III, M., van As, N. (eds) Radiotherapy in Prostate Cancer. Medical Radiology(). Springer, Berlin, Heidelberg. https://doi.org/10.1007/174_2013_950
Download citation
DOI: https://doi.org/10.1007/174_2013_950
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-37098-4
Online ISBN: 978-3-642-37099-1
eBook Packages: MedicineMedicine (R0)